[ad_1] Ascendis raised to outperform by Oppenheimer ahead of drug launch [ad_2] Source: Seekingalpha
Browsing: ahead
[ad_1] Ascendis raised to outperform by Oppenheimer ahead of drug launch [ad_2] Source: Seekingalpha
[ad_1] Ascendis raised to outperform by Oppenheimer ahead of drug launch [ad_2] Source: Seekingalpha
[ad_1] Ascendis raised to outperform by Oppenheimer ahead of drug launch [ad_2] Source: Seekingalpha
[ad_1] Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts [ad_2] Source: Seekingalpha
[ad_1] Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts [ad_2] Source: Seekingalpha
[ad_1] Genelux started at buy by Roth MKM ahead of Olvi-Vec readouts [ad_2] Source: Seekingalpha
[ad_1] Catalent ends FY24 on a strong note ahead of Novo buyout [ad_2] Source: Seekingalpha
[ad_1] sutthirat sutthisumdang Roth MKM started protection of Genelux (NASDAQ:GNLX) with a buy score, citing the corporate’s drug Olvi-Vec within the remedy of ovarian most cancers.…
[ad_1] South Korea’s Seoul Incheon Airport got here in third, adopted by Qatar’s Doha Hamad and Italy’s Rome Fiumicino. The remainder of the highest 10 have…